GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding GENELUX Corp changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 58 | 1 | 75 | +18 |
| Shares | 4.87M | 5.00K | 7.30M | +2.43M (+50.0%) |
| Value | $11.5M | $11.8K | $19.7M | +$8.21M (+71.5%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (26)
Institutions that held GENELUX Corp at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (8)
Institutions that held GENELUX Corp at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Marshall Wace, LLP | 156,058 | $368.3K |
| Axxcess Wealth Management, LLC | 16,668 | $39.3K |
| Man Group plc | 16,656 | $39.3K |
| Virtu Financial LLC | 10,454 | $25.0K |
| Coppell Advisory Solutions LLC | 3,001 | $7.20K |
| Tower Research Capital LLC (TRC) | 592 | $1.40K |
| Allworth Financial LP | 162 | $511 |
| Citigroup Inc | 8 | $19 |
Not filed for Q1 2025 yet (1)
Institutions that held GENELUX Corp at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Global Retirement Partners, LLC | 5,000 | $11.8K |